ArticleBlood research2019

Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation.

Pasquale Niscola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.